Actuate Prices $11M Offering at Steep Discount, Warrants Add Overhang
ACTU is trading near its 52-week low of $0.41 (4.4% above the low).
Summary
Actuate priced an $11.0M underwritten offering of 30,985,900 shares plus warrants at $0.71 per two shares and one warrant — roughly a 17% discount to the $0.4279 last price, and far below the $1.00 assumed price in the Oct. 19 S-1/A refiling. The warrants carry a $0.45 strike over a five-year term, adding an overhang worth about $7.0M in extra cash only if exercised. This is a heavily dilutive raise for a micro-cap that the Q2 10-Q said had cash runway only to September 2026, so the cash is survival capital, not growth capital. A 45-day underwriter option could expand the deal and dilute further. Closing is expected Oct. 28, 2026.
At the time of this announcement, ACTU was trading at $0.43 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $12.7M. The 52-week trading range was $0.41 to $7.90. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Wiseek News.